- Home
- IOVA vs SHLS Comparison
IOVA vs SHLS Comparison
Compare IOVA & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- SHLS
- Stock Information
- Founded
- IOVA 2007
- SHLS 1996
- Country
- IOVA United States
- SHLS United States
- Employees
- IOVA N/A
- SHLS N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- SHLS Semiconductors
- Sector
- IOVA Health Care
- SHLS Technology
- Exchange
- IOVA Nasdaq
- SHLS Nasdaq
- Market Cap
- IOVA 975.1M
- SHLS 1.1B
- IPO Year
- IOVA N/A
- SHLS 2021
- Fundamental
- Price
- IOVA $2.31
- SHLS $10.51
- Analyst Decision
- IOVA Buy
- SHLS Buy
- Analyst Count
- IOVA 11
- SHLS 19
- Target Price
- IOVA $11.90
- SHLS $8.06
- AVG Volume (30 Days)
- IOVA 10.3M
- SHLS 7.5M
- Earning Date
- IOVA 11-06-2025
- SHLS 11-04-2025
- Dividend Yield
- IOVA N/A
- SHLS N/A
- EPS Growth
- IOVA N/A
- SHLS N/A
- EPS
- IOVA N/A
- SHLS 0.12
- Revenue
- IOVA $241,525,000.00
- SHLS $400,354,000.00
- Revenue This Year
- IOVA $68.14
- SHLS $18.14
- Revenue Next Year
- IOVA $56.64
- SHLS $14.50
- P/E Ratio
- IOVA N/A
- SHLS $83.29
- Revenue Growth
- IOVA 636.99
- SHLS N/A
- 52 Week Low
- IOVA $1.64
- SHLS $2.71
- 52 Week High
- IOVA $12.51
- SHLS $11.31
- Technical
- Relative Strength Index (RSI)
- IOVA 53.84
- SHLS 69.18
- Support Level
- IOVA $2.13
- SHLS $9.57
- Resistance Level
- IOVA $2.31
- SHLS $11.29
- Average True Range (ATR)
- IOVA 0.13
- SHLS 0.76
- MACD
- IOVA 0.02
- SHLS 0.13
- Stochastic Oscillator
- IOVA 72.97
- SHLS 79.56
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.